Checkpoint Therapeutics, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
SPOTLIGHT ASSET GROUP, INC. | 05/16/2023 | 661,597 | $622,000 | 100.00% | 5.63% |
COWEN AND COMPANY, LLC | 05/09/2023 | 220,000 | $495,000 | 100.00% | 1.87% |
NEWEDGE ADVISORS, LLC | 05/12/2023 | 26,000 | $58,500 | 136.36% | 0.22% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 05/15/2023 | 16,265 | $36,596 | 29.46% | 0.14% |
XTX TOPCO LTD | 05/12/2023 | 10,125 | $22,781 | 100.00% | 0.09% |
BARTLETT & CO. WEALTH MANAGEMENT LLC | 02/14/2024 | 5,000 | $11,250 | 0.00% | 0.04% |
BARTLETT & CO. LLC | 04/06/2023 | 5,000 | $11,000 | 0.00% | 0.04% |
BELPOINTE ASSET MANAGEMENT LLC | 05/15/2023 | 85 | $191 | 0.00% | 0.00% |
FORTIS CAPITAL ADVISORS, LLC | 05/15/2023 | 52 | $117 | 0.00% | 0.00% |
PARK AVENUE SECURITIES LLC | 04/18/2023 | 0 | $0 | -100.00% | 0.00% |
ROCKEFELLER CAPITAL MANAGEMENT L.P. | 05/16/2023 | 0 | $0 | -100.00% | 0.00% |
TRADITION WEALTH MANAGEMENT, LLC | 05/12/2023 | 0 | $0 | -100.00% | 0.00% |
Checkpoint Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 31 institutional investors and hedge funds held shares of Checkpoint Therapeutics, Inc.. The most heavily invested institutionals were:
Kestra Advisory Services, LLC: 329,281
BlackRock Funding, Inc. /DE: 285,252
Gladstone Institutional Advisory LLC: 61,399
PARK AVENUE SECURITIES LLC: 59,915
Walleye Capital LLC: 44,500
180 WEALTH ADVISORS, LLC: 44,300
5.63% of Checkpoint Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 3.08 M shares in the last 24 months. This purchase volume represents approximately $12.52 M in transactions.